BioCentury
ARTICLE | Company News

Ablitech musculoskeletal, drug delivery news

October 17, 2011 7:00 AM UTC

The U.S. Department of Defense granted Ablitech a $2 million grant to develop its Versadel short interfering RNA delivery technology to treat heterotopic ossification, a random painful growth that occ...